Price Alert: Shares of Vyant Bio (VYNT) Trade 7.04% Higher at Midday August 4

Equities Staff  |

Vyant Bio Inc (NASDAQ: VYNT) has climbed $0.057 (7.04%) and sits at $0.87, as of 12:09:50 est on August 4.

31,878 shares have been traded today.

The Company has fallen 8.99% over the last 5 days and shares fell 1.30% over the last 30 days.

Vyant Bio is set to release earnings on 2022-08-15.

For technical charts, analysis, and more on Vyant Bio visit the company profile.

About Vyant Bio Inc

Vyant Bio operates two wholly-owned subsidiaries, StemoniX and vivoPharm. The Company will immediately begin to execute on the integration of these two leading businesses, to converge human-powered scientific and technology-based systems and expertise with years of preclinical experience to de-risk and accelerate discovery and development of preclinical and clinical pipelines for biopharma partners as well as for the proprietary pipeline of the Company.

To get more information on Vyant Bio Inc and to follow the company's latest updates, you can visit the company's profile page here: Vyant Bio Inc's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Trending Articles

The Strong Dollar Is a Problem for Stocks
3 Ways Finance Teams Can Navigate Inflation Through Automation



Market Movers

Sponsored Financial Content